Curia

CuriaCuria
Curia

Curia

Global contract research, development, and manufacturing organization for pharmaceutical and biopharmaceutical industries.

DR 52Speed 591991Active3386Albany, United States
Rate

About

Curia (formerly AMRI) is a global contract research, development, and manufacturing organization (CDMO) that provides services from drug discovery through commercial manufacturing. They partner with pharmaceutical and biotechnology companies to accelerate the development of life-changing therapies. Curia operates an integrated network of facilities across North America, Europe, and India, offering expertise in small molecules, generic APIs, sterile drug product, and biologics.
Frequently asked

What does Curia do?

Curia (formerly AMRI) is a global contract research, development, and manufacturing organization (CDMO) that provides services from drug discovery through commercial manufacturing. They partner with pharmaceutical and biotechnology companies to accelerate the development of life-changing therapies. Curia operates an integrated network of facilities across North America, Europe, and India, offering expertise in small molecules, generic APIs, sterile drug product, and biologics.

What is Curia's valuation?

StartupHub estimates Curia's effective valuation at $244.3M (range $140.8M to $337.8M, 10% confidence), based on comparable companies in the sector.

How much funding has Curia raised?

Curia has raised a total of $56M in funding. The most recent round on record is IPO.

Where is Curia headquartered?

Curia is headquartered in Albany, United States.

When was Curia founded?

Curia was founded in 1991.

What industry does Curia operate in?

Curia operates in Contract Research Organization, Contract Development and Manufacturing Organization (CDMO), Drug Discovery, Drug Development, cGMP Manufacturing, Aseptic Fill and Finish.

How many employees does Curia have?

Curia has approximately 3386 people on record.

HEADCOUNT
3386
DOMAIN RATING
52
Comments

No comments yet. Be the first to share your take.